Calcium pyrophosphate deposition disease (CPPD) typically involves the knees and wrists, but a new case report describes crystal‑proven CPPD of the sternoclavicular joint. Read the full text for free: https://t.co/8z13WXXMkB @RLWBowman@AHAScience#AHAJournals
🚨NEW Publication in @ACR_Journals🚨
with @dredithwilliams & team!
Limited #HealthLiteracy in pts w/ SLE was associated with worse outcomes:
• ↓self-efficacy, pt activation, QOL
• worse physician/pt communication
• ↑disease activity (SLAQ), ↑damage
https://t.co/ThDM0f9iEt
💜 Today is #WorldLupusDay! Let’s take time today to shine a light on #lupus, honor every lupus champion, and celebrate all who are making a difference. We stand together! You are not alone. #ManyOneCan get involved: https://t.co/QrJm9szYG3 #LupusAwarenessMonth
13 Risk Factors for RA-associated Interstitial Lung Disease (ILD)
ILD is the most widespread and fatal pulmonary complication of rheumatoid arthritis (RA). A recent metanalysis shows the pooled prevalence of RA-ILD was approximately 18.7%.
https://t.co/oqb37RWPuZ
Rosalind Ramsey-Goldman, MD (@ramseygoldmanmd), and Irene Blanco, MD (@IreneBlancoMD), contributed their expertise to “Living Well With Lupus: A Toolkit for Women,” created by @SWHR. This guide provides helpful resources for women living with #Lupus.
https://t.co/TaPeedxjwx
The first person has been treated in a Phase 1 study of the CAR-T cell therapy, CC-97540, for treatment of severe #lupus. Read the announcement: https://t.co/QZVT14LLl0
Congrats to @KronzerMD for leading this work - Association between sinusitis and incident rheumatic diseases
Upper respiratory tracts, not just lungs, may be important for pathogenesis of many rheumatic diseases (RA, APS, SjD, Vasculitis, PMR)
https://t.co/qc8cvckfh5
A series of topical #antimicrobials derived from the Queensland blushwood tree can eradicate bacterial biofilms and infections in chronic skin wounds and accelerate #WoundHealing in mice and large animals, according to a new study in @ScienceTM. https://t.co/iTmx9OtoAR
“Fatigue is one of the most prevalent symptoms in SLE, reported by 67% to 90% of patients. It is also described as the most bothersome symptom, considering that it may impair key aspects of health-related quality of life, while also leading to employment disability.”
Among patients with active polymyalgia rheumatica receiving glucocorticoid therapy, the addition of tocilizumab, vs placebo, resulted in improved disease activity scores with reduced prednisone dosage at 24 wks; additional research is needed. https://t.co/3gM836Pe3w #Research